A detailed history of Quantinno Capital Management LP transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Quantinno Capital Management LP holds 53,183 shares of EW stock, worth $3.94 Million. This represents 0.05% of its overall portfolio holdings.

Number of Shares
53,183
Previous 41,155 29.23%
Holding current value
$3.94 Million
Previous $3.8 Million 7.68%
% of portfolio
0.05%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$59.7 - $93.78 $718,071 - $1.13 Million
12,028 Added 29.23%
53,183 $3.51 Million
Q2 2024

Aug 14, 2024

SELL
$84.3 - $94.31 $355,998 - $398,271
-4,223 Reduced 9.31%
41,155 $3.8 Million
Q1 2024

May 14, 2024

BUY
$72.54 - $95.56 $2.55 Million - $3.36 Million
35,161 Added 344.14%
45,378 $4.34 Million
Q4 2023

Feb 14, 2024

SELL
$61.71 - $77.76 $632,527 - $797,040
-10,250 Reduced 50.08%
10,217 $779,000
Q3 2023

Nov 14, 2023

SELL
$69.28 - $93.38 $886,368 - $1.19 Million
-12,794 Reduced 38.47%
20,467 $1.42 Million
Q2 2023

Aug 04, 2023

BUY
$81.41 - $94.33 $1.02 Million - $1.18 Million
12,529 Added 60.43%
33,261 $3.14 Million
Q1 2023

May 03, 2023

BUY
$74.26 - $84.51 $207,333 - $235,951
2,792 Added 15.56%
20,732 $1.72 Million
Q4 2022

Feb 13, 2023

BUY
$68.3 - $87.44 $1.02 Million - $1.31 Million
14,925 Added 495.02%
17,940 $1.34 Million
Q3 2022

Nov 07, 2022

BUY
$82.37 - $107.29 $17,956 - $23,389
218 Added 7.79%
3,015 $249,000
Q2 2022

Aug 15, 2022

BUY
$86.5 - $128.27 $241,940 - $358,771
2,797 New
2,797 $266,000
Q2 2020

Aug 14, 2020

SELL
$57.54 - $76.95 $189,421 - $253,319
-3,292 Closed
0 $0
Q1 2020

May 15, 2020

BUY
$52.41 - $81.0 $172,533 - $266,652
3,292 New
3,292 $621,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Quantinno Capital Management LP Portfolio

Follow Quantinno Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantinno Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantinno Capital Management LP with notifications on news.